Vitamin patch brand Barrière announced the launch of the first supplement patch designed to treat lactose intolerance [1].
This move signals a shift toward transdermal delivery in the supplement industry, offering an alternative to traditional oral pills for those with dietary restrictions.
The new product provides a solution for lactose intolerance with a wear time of up to 12 hours [3]. By utilizing a transdermal method, the company aims to disrupt the existing supplement market and provide a more convenient delivery system for users.
Barrière is scaling its physical presence significantly through a new retail agreement. The company has secured product placement in 1,700 Walmart stores across the U.S. [1]. This expansion is intended to increase accessibility for consumers who prefer shopping at big-box retailers over online marketplaces.
Financially, the company has set aggressive growth targets. Barrière said it will double its current revenue to reach $10 million by 2026 [1]. This projection follows the company's strategy to move beyond niche vitamin patches into broader health and wellness categories.
The company first announced the product launch in 2024 as part of its effort to compete with established brands like Lactaid [2, 3]. The transition to a wearable format is designed to simplify the process of managing lactose intolerance throughout the day.
“Barrière has secured product placement in 1,700 Walmart stores across the U.S.”
The expansion into 1,700 retail locations and the introduction of a first-of-its-kind lactose intolerance patch indicate a strategic pivot toward mass-market healthcare. By moving from general vitamins to specific digestive health solutions, Barrière is attempting to capture a larger share of the supplement market through convenience and a different delivery mechanism than traditional oral medication.
